Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial
Source: Reuters
BUSINESS NEWS MARCH 25, 2019 / 4:48 PM / UPDATED 7 HOURS AGO
Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial
Nate Raymond
3 MIN READ
(Reuters) - Oklahomas top court on Monday declined to delay a landmark trial set for May in a multibillion-dollar lawsuit accusing OxyContin maker Purdue Pharma LP and two other drugmakers of helping fuel an opioid abuse and overdose epidemic in the state.
The Oklahoma Supreme Courts decision was a win for the states attorney general, whose case is set to be the first to face trial of roughly 2,000 lawsuits nationally seeking to hold opioid manufacturers responsible for contributing to the epidemic.
Oklahoma Attorney General Mike Hunters 2017 lawsuit accuses Purdue, Johnson & Johnson & Teva Pharmaceutical Industries Ltd of engaging in deceptive marketing that downplayed the risks of addiction associated with opioid pain drugs while overstating their benefits.
The companies deny wrongdoing. They had sought to delay the May 28 trial to Sept. 16, citing the need to review records the state belatedly turned over that could be critical to their defense. The state is seeking over $20 billion in damages.
-snip-
Read more:
https://www.reuters.com/article/us-usa-opioids-litigation/oklahoma-top-court-clears-way-for-purdue-jj-teva-to-face-opioid-trial-idUSKCN1R62JK